|
Pharmaids Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
209.98 Cr.
|
P/BV
|
3.13
|
Book Value (Rs.)
|
19.04
|
|
52 Week High/Low (Rs.)
|
87/32
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
24/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| PER SHARE RATIOS | | | | |
| | | | | |
| Basic EPS (Rs.) | -3.05 | -3.56 | -5.86 | 0.14 |
| Diluted EPS (Rs.) | -3.05 | -3.56 | -5.86 | 0.14 |
| Cash EPS (Rs.) | -3.14 | -2.87 | -3.52 | 0.15 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 16.82 | 19.99 | 10.47 | 8.44 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 16.82 | 19.99 | 10.47 | 8.44 |
| Revenue From Operations / Share (Rs.) | 5.51 | 4.28 | 0.00 | 3.84 |
| PBDIT / Share (Rs.) | -3.59 | -3.50 | -4.61 | 0.14 |
| PBIT / Share (Rs.) | -4.28 | -3.98 | -4.62 | 0.13 |
| PBT / Share (Rs.) | -4.90 | -4.43 | -4.62 | 0.13 |
| Net Profit / Share (Rs.) | -3.83 | -3.36 | -3.52 | 0.14 |
| NP After MI And SOA / Share (Rs.) | -3.06 | -2.26 | -3.52 | 0.14 |
| | | | | |
| PROFITABILITY RATIOS | | | | |
| | | | | |
| PBDIT Margin (%) | -65.06 | -81.57 | 0.00 | 3.86 |
| PBIT Margin (%) | -77.61 | -92.99 | 0.00 | 3.63 |
| PBT Margin (%) | -88.85 | -103.37 | 0.00 | 3.56 |
| Net Profit Margin (%) | -69.44 | -78.36 | 0.00 | 3.68 |
| NP After MI And SOA Margin (%) | -55.41 | -52.72 | 0.00 | 3.68 |
| Return on Networth / Equity (%) | -18.16 | -11.05 | -33.64 | 1.67 |
| Return on Capital Employeed (%) | -16.56 | -17.61 | -44.09 | 1.64 |
| Return On Assets (%) | -8.99 | -8.72 | -30.72 | 1.30 |
| Long Term Debt / Equity (X) | 0.50 | 0.04 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.59 | 0.07 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.18 | 0.26 | 0.00 | 0.00 |
| | | | | |
| LIQUIDITY RATIOS | | | | |
| | | | | |
| Current Ratio (X) | 0.77 | 1.17 | 8.23 | 1.09 |
| Quick Ratio (X) | 0.35 | 0.85 | 8.23 | 0.72 |
| Inventory Turnover Ratio (X) | 1.13 | 0.00 | 0.00 | 0.00 |
| | | | | |
| COVERAGE RATIOS | | | | |
| | | | | |
| Interest Coverage Ratio (%) | -6.06 | -7.86 | -2135.71 | 55.63 |
| Interest Coverage Ratio (Post Tax) (%) | -5.42 | -6.55 | -1631.24 | 54.05 |
| | | | | |
| VALUATION RATIOS | | | | |
| | | | | |
| Enterprise Value (Cr.) | 271.01 | 182.39 | 34.01 | 12.44 |
| EV / Net Operating Revenue (X) | 13.94 | 12.07 | 0.00 | 3.16 |
| EV / EBITDA (X) | -21.42 | -14.79 | -3.44 | 81.73 |
| MarketCap / Net Operating Revenue (X) | 12.45 | 12.14 | 0.00 | 3.26 |
| Price / BV (X) | 4.08 | 2.55 | 2.08 | 1.48 |
| Price / Net Operating Revenue (X) | 12.45 | 12.14 | 0.00 | 3.26 |
| EarningsYield | -0.04 | -0.04 | -0.16 | 0.01 |
